fbpx

Bio & Life Sciences

A New Climate Change Threat: Fungal Killers

There are more than 6 million species of fungi, but just a handful are known to be pathogenic to humans. Nevertheless, one expert says fungi may be world's biggest health threat.   More

Bio & Life Sciences Innovation Science

As Gene Editing Advances, Scientists Race to Set Boundaries

Around the world, leading scientific organizations are moving quickly to implement new guidelines to govern the use of gene editing.   More

Bio & Life Sciences Science

Why We Need to Learn the Language of DNA

Even super smart people don’t really understand genetics. To solve the problem, experts must do one key thing: translate technical concepts into simple terms.   More

Bio & Life Sciences Healthcare

Under the Weather? Time to Check Your Microbes.

There's a new wave of research about microbiomes--trillions of microbes that cover our bodies. The research could lead to products that improve our health.   More

Bio & Life Sciences Policy Science

Can a Company Claim Your Genes?

Congress is weighing a bipartisan proposal to allow patents for naturally occurring things like genes and organisms.   More

Bio & Life Sciences Inclusion Leadership

Noticing More Women in STEM? Here’s One Reason Why.

This strategy is boosting representation of women in science, tech, engineering and math—and could inspire young girls to enter the field.   More

Bio & Life Sciences Healthcare

Why Do Kids Get Cancer? Promising Research is Underway.

Understanding how an old person’s disease develops in kids could offer clues about how to predict, or maybe even prevent, pediatric cancers.   More

Bio & Life Sciences Partner Insights

Why a Memory Chipmaker Cares About Health AI

New techniques for information storage and retrieval will be essential for enabling the next wave of healthcare innovation.   More

Bio & Life Sciences

Why Measuring “Frailty” May Enable Cancer Progress

An unlikely partnership could make more cancer patients eligible for clinical trials—and improve lives. The key is more accurately assessing patient frailty. Meredith Salisbury explains.   More

Bio & Life Sciences Science

Experts Note ‘Tremendous Progress’ on Cancer

Significant progress has been made in the fight against cancer in recent years, but funding, clinical trial access, and navigating increasingly complex data sets are among the latest challenges. "Now is an exceptional time in cancer research,” says the director of the National Cancer Institute, “the tremendous progress we have made … is amazing.”   More

Bio & Life Sciences Healthcare Science

Why Thursday Is Rare Disease Day

With the exception of primetime medical dramas, you don’t hear much about rare diseases. But just because they’re “rare” — in the U.S., that’s a guideline used for diseases affecting fewer than 200,000 Americans — doesn’t mean they’re scarce. Rare Disease Day, held this year on February 28th, raises awareness for rare diseases and reminds us that these conditions have an outsize impact.   More

Bio & Life Sciences Healthcare Opinion

Skeptics Unfairly Target UK Gene Sequencing Initiative

A new UK initiative has stirred debate about DNA analysis for healthy people. The program allows patients to pay to get their genome sequenced and analyzed if they agree to let the data be used in research. Author Salisbury says the UK controversy largely misses the point.   More

Bio & Life Sciences Techonomy Events

We’re Close to Replacing the MRI with a Hat

How about replacing big, expensive MRI and other imaging equipment with a hat or a scarf? Mary Lou Jepsen showed the audience at Techonomy 2018 just how close it is to reality.   More

Bio & Life Sciences Healthcare

Genomic Study Offers Hope for Millions with Rare Diseases

A new study makes the case that genomic medicine can be cost effective in diagnosing rare diseases, offering a potential alternative path for millions of patients worldwide.   More

Bio & Life Sciences Healthcare

Critical Genomic Breakthrough Should Help Identify Disease Risk

A new report suggests that an innovative method of analyzing DNA will allow medical researchers to predict disease risk for far more people than can be done with conventional medical tests.   More

Bio & Life Sciences Healthcare Opinion

Why I Joined a Research Study — and You Should Too

In which our intrepid reporter gives her very blood to stay on the front lines of modern healthcare.   More

Bio & Life Sciences Healthcare

New Cancer Concerns Shake Up CRISPR Prognosis

New studies connect gene editing with CRISPR technology to cancer, sending stocks plummeting and raising serious questions about the technology's potential.   More

Bio & Life Sciences

CRISPR Community Wrestles With Potential and Peril of Gene Editing

Scientists, academics and other stakeholders gathering in Boston lauded the potential of what CRISPR-powered innovation could offer society — and grappled with potential negative or unintended consequences from the still-nascent technology.   More

Bio & Life Sciences Science

I Got My Genetic Results. Now What? A Techonomy Guide

Genetic testing has become more mainstream and greater numbers of consumers are receiving their results — and left wondering what they mean and what to do with them. For those who need help navigating and understanding everything from so-called recreational genetic tests to potentially scary medical tests, this guide is for you.   More

Bio & Life Sciences Community Insights

Happy 15th Birthday, Human Genome Project

This month marks the 15th anniversary of the completion of the Human Genome Project. While the main goal of the project has not been fully realized, we are closer than ever to reaching it. Meredith Salisbury walks us through the ongoing benefits.   More